Herbert Gottweis, Brian Salter, and Catherine Waldby, The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition (New York: Palgrave MacMillan, 2009), 272 pages. ISBN 978-0230002630, Hardcover, $90.00.

2010 ◽  
Vol 29 (1) ◽  
pp. 100-102
Author(s):  
Arthur W. Blaser
Keyword(s):  
New York ◽  
Stem Cell ◽  
Regenerative Medicine ◽  
Embryonic Stem Cell ◽  
Human Embryonic Stem Cell ◽  
Embryonic Stem ◽  
Global Politics ◽  
Stem Cell Science

RESEARCH FINDINGS

2011 ◽  
Vol 15 (12) ◽  
pp. 43-44
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Kawasaki Disease ◽  
Regenerative Medicine ◽  
Embryonic Stem Cell ◽  
Human Embryonic Stem Cell ◽  
Embryonic Stem ◽  
Medicine Research ◽  
Research Findings ◽  
Cell Study

Singapore Scientists Lead Human Embryonic Stem Cell Study to Advance Regenerative Medicine Research. Singapore Scientists Discover Genetic Link in Kawasaki Disease. Stem Cells Engineered to Kill Cancer.

scholarly journals Human embryonic stem cell-derived mesenchymal progenitors—Potential in regenerative medicine

2009 ◽  
Vol 3 (1) ◽  
pp. 39-50 ◽  
Author(s):  
Camilla Karlsson ◽  
Katarina Emanuelsson ◽  
Fredrik Wessberg ◽  
Kristina Kajic ◽  
Mathilda Zetterström Axell ◽  
...  
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Embryonic Stem Cell ◽  
Human Embryonic Stem Cell ◽  
Embryonic Stem ◽  
Mesenchymal Progenitors

scholarly journals Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic

2015 ◽  
Vol 370 (1680) ◽  
pp. 20140375 ◽  
Author(s):  
Paul Whiting ◽  
Julie Kerby ◽  
Peter Coffey ◽  
Lyndon da Cruz ◽  
Ruth McKernan
Keyword(s):  
Stem Cell ◽  
Regenerative Medicine ◽  
Embryonic Stem Cell ◽  
Human Embryonic Stem Cell ◽  
Pigment Epithelium ◽  
Retinal Pigment ◽  
Retinal Pigment Epithelium Cell ◽  
Embryonic Stem ◽  
Retinal Disease ◽  
Current Status

Since the first publication of the derivation of human embryonic stem cells in 1998, there has been hope and expectation that this technology will lead to a wave of regenerative medicine therapies with the potential to revolutionize our approach to managing certain diseases. Despite significant resources in this direction, the path to the clinic for an embryonic stem-cell-based regenerative medicine therapy has not proven straightforward, though in the past few years progress has been made. Here, with a focus upon retinal disease, we discuss the current status of the development of such therapies. We also highlight some of our own experiences of progressing a retinal pigment epithelium cell replacement therapy towards the clinic.

Sign in / Sign up

Export Citation Format

Share Document